Systemic light chain amyloidosis: an update for treating physicians
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic light chain amyloidosis: an update for treating physicians
Authors
Keywords
-
Journal
BLOOD
Volume 121, Issue 26, Pages 5124-5130
Publisher
American Society of Hematology
Online
2013-05-14
DOI
10.1182/blood-2013-01-453001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
- (2013) A. D. Wechalekar et al. BLOOD
- Left ventricular device implantation for advanced cardiac amyloidosis
- (2013) Paul L. Swiecicki et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure
- (2012) Giovanni Palladini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis
- (2012) Jean D. Sipe et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- CyBorD: stellar response rates in AL amyloidosis
- (2012) G. Merlini BLOOD
- Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis
- (2012) J. R. Mikhael et al. BLOOD
- Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival
- (2012) C. P. Venner et al. BLOOD
- A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis
- (2012) E. Kastritis et al. BLOOD
- Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis
- (2012) A. Dispenzieri et al. BLOOD
- Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
- (2012) S. K. Kumar et al. BLOOD
- Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
- (2012) M A Gertz et al. BONE MARROW TRANSPLANTATION
- Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis
- (2012) Sanjay M. Banypersad et al. Circulation-Cardiovascular Imaging
- New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
- (2012) Giovanni Palladini et al. JOURNAL OF CLINICAL ONCOLOGY
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements
- (2012) Shaji Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosis
- (2012) Sebastian J. Buss et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
- (2012) H Landau et al. LEUKEMIA
- Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
- (2012) R L Comenzo et al. LEUKEMIA
- The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients
- (2011) A. Foli et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide
- (2011) Giovanni Palladini et al. ANNALS OF HEMATOLOGY
- Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)
- (2011) T. Bochtler et al. BLOOD
- Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients
- (2011) M. T. Cibeira et al. BLOOD
- Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study
- (2011) D. E. Reece et al. BLOOD
- Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients
- (2011) S. O. Schonland et al. BLOOD
- The repertoire of light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44
- (2011) V. Perfetti et al. BLOOD
- Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue
- (2011) F. Brambilla et al. BLOOD
- Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis
- (2011) A. D. Wechalekar et al. HAEMATOLOGICA
- Outcome in Renal AL Amyloidosis After Chemotherapy
- (2011) Jennifer H. Pinney et al. JOURNAL OF CLINICAL ONCOLOGY
- Amyloidosis: Pathogenesis and New Therapeutic Options
- (2011) Giampaolo Merlini et al. JOURNAL OF CLINICAL ONCOLOGY
- Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs
- (2010) Angela Dispenzieri et al. AMERICAN JOURNAL OF HEMATOLOGY
- Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay
- (2010) A. V. Kristen et al. BLOOD
- The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis
- (2010) G. Palladini et al. BLOOD
- Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
- (2010) P. Moreau et al. BLOOD
- Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement
- (2010) S. Dietrich et al. BLOOD
- Transplantation vs. conventional-dose therapy for amyloidosis
- (2010) Giovanni Palladini et al. CURRENT OPINION IN ONCOLOGY
- Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy
- (2010) Claudio Rapezzi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
- (2010) Efstathios Kastritis et al. JOURNAL OF CLINICAL ONCOLOGY
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
- (2010) R A Kyle et al. LEUKEMIA
- Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
- (2010) Morie A. Gertz et al. LEUKEMIA & LYMPHOMA
- Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score
- (2010) Shaji K. Kumar et al. MAYO CLINIC PROCEEDINGS
- Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
- (2010) Karl Bodin et al. NATURE
- Kidney dysfunction during lenalidomide treatment for AL amyloidosis
- (2010) R. Specter et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiac Transplantation Followed by Dose-Intensive Melphalan and Autologous Stem-Cell Transplantation for Light Chain Amyloidosis and Heart Failure
- (2010) Bimalangshu R. Dey et al. TRANSPLANTATION
- Structural Typing of Systemic Amyloidoses by Luminescent-Conjugated Polymer Spectroscopy
- (2009) K. Peter R. Nilsson et al. AMERICAN JOURNAL OF PATHOLOGY
- Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis
- (2009) Saulius Girnius et al. ANNALS OF HEMATOLOGY
- Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens
- (2009) J. A. Vrana et al. BLOOD
- Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine
- (2009) G. Palladini et al. CLINICAL CHEMISTRY
- Autologous Stem Cell Transplant after Heart Transplant for Light Chain (AL) Amyloid Cardiomyopathy
- (2008) Martha Q. Lacy et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis☆
- (2007) Falk-Udo Sack et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More